... bought a new stake in shares of Biohaven Pharmaceutical in the second quarter valued at approximately $790,000. Ardsley Advisory Partners bought a new stake in shares of Biohaven Pharmaceutical in the second quarter valued at approximately $395,000. ...
https://sportsperspectives.com/2018/08/25/biohaven-pharmaceutical-bhvn-receives-new-coverage-from-analysts-at-cantor-fitzgerald.html
No comments:
Post a Comment